Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10161029 | 2010-04-26 | ||
EP10161032 | 2010-04-26 | ||
EP10161034 | 2010-04-26 | ||
EP10195766 | 2010-12-17 | ||
EP10195764 | 2010-12-17 | ||
EP10195760 | 2010-12-17 |
Publication Number | Publication Date |
---|---|
AR081542A1true AR081542A1 (es) | 2012-10-03 |
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110101417AAR081542A1 (es) | 2010-04-26 | 2011-04-25 | Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno |
Country | Link |
---|---|
US (4) | US8476252B2 (es) |
EP (4) | EP2857042B1 (es) |
JP (1) | JP5886273B2 (es) |
KR (1) | KR101822680B1 (es) |
CN (2) | CN102946865B (es) |
AR (1) | AR081542A1 (es) |
AU (1) | AU2011246527B2 (es) |
BR (1) | BR112012027279B1 (es) |
CA (2) | CA2797253C (es) |
EA (1) | EA022460B1 (es) |
ES (4) | ES2576190T3 (es) |
GE (1) | GEP20166457B (es) |
HK (1) | HK1181998A1 (es) |
IL (2) | IL222710A (es) |
MX (1) | MX2012012491A (es) |
MY (1) | MY156858A (es) |
NZ (1) | NZ603176A (es) |
PH (1) | PH12012502120B1 (es) |
PL (1) | PL2563335T3 (es) |
PT (1) | PT2563335E (es) |
SG (1) | SG185025A1 (es) |
TW (1) | TW201138782A (es) |
WO (2) | WO2011134937A2 (es) |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
WO2013078422A2 (en) | 2011-11-23 | 2013-05-30 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
IN2014DN08088A (es)* | 2012-02-29 | 2015-05-01 | Braun Melsungen Ag | |
TWI651098B (zh)* | 2012-02-29 | 2019-02-21 | B 柏藍麥桑根公司 | 含荷爾蒙的乳劑 |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
EP2968140A4 (en)* | 2013-03-15 | 2016-11-16 | Pharmagenesis Inc | INTRAVENOUS EMULSIONS OF TRIPTOLIDE AS IMMUNOMODULATORS AND ANTICROBIAL I |
WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
US20160310584A1 (en)* | 2013-12-06 | 2016-10-27 | The Broad Institute Inc. | Formulations for neoplasia vaccines |
WO2015095811A2 (en) | 2013-12-20 | 2015-06-25 | The Board Institute Inc. | Combination therapy with neoantigen vaccine |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10098894B2 (en) | 2014-07-29 | 2018-10-16 | Therapeuticsmd, Inc. | Transdermal cream |
EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
CA2971786A1 (en)* | 2015-03-31 | 2016-10-06 | Fresenius Kabi Deutschland Gmbh | Emulsions for parenteral administration |
BR112017024797A2 (pt) | 2015-05-20 | 2018-08-07 | The Broad Institute Inc. | neoantígenos partilhados |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
EP3435977A4 (en) | 2016-04-01 | 2019-10-16 | Therapeuticsmd, Inc. | PHARMACEUTICAL COMPOSITION OF STEROID HORMONE |
CN106074383B (zh)* | 2016-07-27 | 2019-03-08 | 武汉科福新药有限责任公司 | 孕激素药物脂微球注射液及其制备方法 |
US20180207097A1 (en)* | 2017-01-23 | 2018-07-26 | Government Of The United States As Represented By The Secretary Of The Air Force | Non-toxic vehicle to solubilize, deliver, and obtain biological activity of steroid hormones at cell, tissue, and organ targets, in vitro and in vivo |
EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
KR20210102936A (ko)* | 2018-12-10 | 2021-08-20 | 헤일로 사이언스 엘엘씨 | 안정적인 마취제 제제 및 관련 복용량 형태 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
EP3878434A1 (en)* | 2020-03-12 | 2021-09-15 | Lipoid GmbH | Sunflower phospholipid composition containing phosphatidylcholine |
US20230098327A1 (en)* | 2021-08-30 | 2023-03-30 | Premier Nutrition Company, Llc | Sleep-inducing beverage composition, its method of production and the method of use |
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60258110A (ja) | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
US5364632A (en)* | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
IL89856A (en) | 1989-04-05 | 1993-05-13 | Yissum Res Dev Co | Medical emulsions for liphophilic drugs containing a medium-chain triglyceride oil as a carrier |
SE9301171D0 (sv)* | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
HUP0202235A3 (en) | 1999-07-22 | 2004-05-28 | Aventis Pharmaceuticals Inc Br | Preserved pharmaceutical formulations |
US6720001B2 (en)* | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
US6327968B1 (en) | 2000-03-17 | 2001-12-11 | Pizza Hut, Inc. | System and method for producing par-baked pizza crusts |
EP1488785A1 (de) | 2003-06-18 | 2004-12-22 | B. Braun Melsungen Ag | Ölemulsion zur postnatalen Hormonsubstitution |
WO2005105040A2 (en) | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
EP1611879B1 (en) | 2004-07-02 | 2009-08-12 | Novagali Pharma SA | Use of emulsions for intra- and periocular injection |
US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
EP2431042B1 (en) | 2005-03-24 | 2013-06-26 | Emory University | Methods for the treatment of central nervous system injury via a tapered administration protocol |
EP2001438A2 (en)* | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
CN101152186B (zh)* | 2007-09-05 | 2011-07-06 | 杭州平和安康医药科技有限公司 | 黄体酮注射液及其制备方法 |
TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
Publication | Publication Date | Title |
---|---|---|
AR081542A1 (es) | Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno | |
CR20220108A (es) | Nanopartículas lipídicas mejoradas para el suministro de ácidos nucleicos | |
CL2017001488A1 (es) | Benzamidas sustituidas con 1,3–tiazol–2–ilo | |
BR112018067586A2 (pt) | composição administrável oralmente | |
AR088382A1 (es) | Formulaciones de etanercept estabilizadas con xilitol | |
GT201500086A (es) | Análogos de 2'-cloro nucleósido para infección por vhc | |
PE20180038A1 (es) | Composiciones farmaceuticas topicas | |
BR112014026118A2 (pt) | métodos relacionados a composições para cuidados pessoais | |
PE20131166A1 (es) | Formulacion de premezcla de dexmedetomidina | |
BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
AR099632A1 (es) | Tratamiento de una infección viral de hepatitis c, que usa una combinación de compuestos | |
MX2016007658A (es) | Composiciones basadas en metil ciclodextrinas para el tratamiento y/o prevencion de enfermedades aumentando el nivel de colesterol hdl. | |
CL2016002276A1 (es) | Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad | |
MX377302B (es) | Composiciones para el cuidado personal con dos fases benéficas. | |
CL2018003110A1 (es) | Preparación y dispersión de formulaciones de emulsión estable. | |
CL2016002400A1 (es) | Formulación para higiene personal | |
CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
CL2012003282A1 (es) | Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros. | |
BR112017006918A2 (pt) | formulações nanoestruturadas para liberação de silibinina e outros ingredientes ativos para o tratamento de doenças oculares | |
PE20170305A1 (es) | Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio | |
UY30676A1 (es) | Microemulsion aceite/agua de propofol estable y lista para uso | |
CL2015001368A1 (es) | Metodo para anticoncepcion controlada que comprende administrar una preparacion farmaceutica que comprende levonorgestrel y un inhibidor de la cox; uso de la composicion farmaceutica en la anticoncepcion "a la carta". | |
BR112016006485A2 (pt) | composições de liberação pulsátil revestidas por compressão | |
MX2015008330A (es) | Composiciones farmaceuticas veterinarias novedosas y un metodo para la produccion de las mismas. | |
TN2012000505A1 (en) | Low-oil pharmaceutical emulsion compositions comprising progestogen |
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |